APNA Clinical Psychopharmacology Institute
Planned for Nurses, by Nurses


APNA 19th Annual Clinical Psychopharmacology Institute
Adapting & Innovating: Psychopharmacologic Nursing Care in the Midst of Crisis

June 10-13, 2021  /  Offered Virtually*

"Other conferences I have attended focused on processes and products, APNA focused on the experience of human problems, the kind of things we are aware of but push past 'in the interest of the patient' ...For me that thinking elevates my practice to serve my patients better."
Anthony Peckham, PMHNP-BC

Announcing the 2021 Keynote Speakers!

Joshua Gordon, MD, PhD

Director, National Institutes of Mental Health
Thursday, June 10, 2021

Dr. Gordon oversees an extensive research portfolio of basic and clinical research at NIMH. His own research focuses on the effects of genes that predispose to psychiatric illnesses.

George Koob, PhD

Director, National Institute on Alcohol Abuse & Alcoholism
Friday, June 11, 2021

An expert in the neurobiology of alcohol and drug addiction, Dr. Koob is recognized internationally for his work with alcohol and stress, including prevention and treatment.

Nina Schooler, PhD

Professor of Psychiatry & Behavioral Sciences, SUNY Downstate Medical Center
Saturday, June 12,

Dr. Schooler’s work centers on the long-term course of schizophrenia and its treatment, from first-episode psychosis to CBT and medication treatment.


Master your psychopharmacologic nursing practice across the lifespan.

The APNA Clinical Psychopharmacology Institute (CPI) delivers psychopharmacology updates to professionals looking to provide the best possible care to their patients. CPI prioritizes the integration of psychopharmacology and neuroscience into clinical practice. It offers the scientific base for treatment decisions and addresses the context of care within the nurse/consumer/family relationship.

Join other providers like you.

The APNA Clinical Psychopharmacology Institute is appropriate for RN-PMH and advanced practice psychiatric nurses - especially those who administer and/or prescribe medications. Because CPI is planned for nurses, by nurses, the program provides a depth and breadth of scientific information tailored to the challenges inherent in psychiatric-mental health nursing practice. All other health care providers interested in psychopharmacology are welcome for advanced study, especially fellow nurses, primary care physicians, psychiatrists, psychologists, and pharmacists.

*Possible in-person component, dependent on public guidelines at date of event.

Access Session Recordings from past APNA Clinical Psychopharmacology Institutes
2020 Attendees: Download your CPI Certificate Here

*The content of this CNE activity pertains to pharmacology. Because states' requirements may vary, contact your Board of Nursing for more information.

The American Psychiatric Nurses Association is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

The American Psychiatric Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.